Ambulatory Care Pharmacy Forum of NC Annual Meeting 2025

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Pharmacists

Description

This program is a hybrid with both in person and webinar attendance options as follows:

Option 1: Attend IN PERSON | Morning and Afternoon Sessions (6 hours of credit total)
Option 2: Attend VIRTUALLY or IN PERSON | Morning Session only (3 hours of credit)
**NO option to attend VIRTUAL or IN PERSON for only the Afternoon Session.

Because of the interactive nature of the afternoon session, there will not be a virtual option for the afternoon session. Participants need to attend IN PERSON.

The Ambulatory Care Pharmacy Forum of North Carolina is a network for and led by ambulatory care pharmacists. The program is intended for clinical pharmacists with an ongoing goal of providing networking, collaboration, and educational opportunities for likeminded pharmacists in North Carolina with an emphasis on practical ambulatory care topics and unmet public health needs. In addition to providing networking opportunities for ambulatory care pharmacist, this application-based CPE activity will provide the pharmacist with clinical practice updates on a variety of topics.

For more information on Ambulatory Care Pharmacy Forum of NC, Click on: www.AmbulatoryCarePharmacyForum.com

Topics and Speakers
Chronic Kidney Disease: Clinical Updates and Navigating Patient Care Through Grey Areas
Lauren Anderson, PharmD, BCACP

To Evenity and Beyond! An Update on Osteoporosis Management
Anne Komé, PharmD, CPP, BCACP, CDCES

Medicare Part D 2025: Highlights and Pitfalls
Gina Upchurch, RPh, MPH

GLP-1 Receptor Agonists Long Term Use and Practical Considerations
Kelsy Combs, PharmD, BCPS, BCACP, CPP

Debunking Direct Oral Anticoagulants in Clinical Practice
Holly Canupp, PharmD, BCACP, CPP, CDCES, FNCAP
Allison Presnell, PharmD, BCACP, BC-ADM, CPP

Involving Pharmacy Learners in Population Health Initiatives
Catie Harper, PharmD, BCACP, CPP
Molly Topp Hinely, PharmD, CPP
Danielle Baker, PharmD, MS, BCPS
Rebecca Grandy, PharmD, BCACP

Location
Atrium Health Cabarrus, Hamrick Theater
920 Church Street North
Concord, NC 28025

Webinar Information
Webinar Available for this program: Participants who are interested in taking this workshop as a webinar, please go to our webinar requirements page for more information and to test your computer and network your computer will be on prior to the class.

The University Of North Carolina Eshelman School Of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program ACPE#0046-9999-24-319-L99-P(Pharmacist) provides 3.0 contact hours of containing pharmacy education credit from 8:30AM to 12Noon. The program ACPE#0046-9999-24-320-L99-P(Pharmacist) provides 3.0 contact hours of containing pharmacy education credit from 1PM to 4:30PM. To receive CE credit, you must complete the CE attendance form and the evaluation of the program. Statement of credit can be viewed and printed in CPE Monitor. Statements of CE Credit will be processed in approximately 2 to 3 weeks.
**No partial credit will be available**

Objectives

• Explain the latest guidelines for the evaluation and management of chronic kidney disease, including key updates from KDIGO 2024.
• Identify medications used in the management of CKD, focusing on their mechanisms, benefits, and potential side effects.
• Identify common medications that are nephrotoxic or require renal dose adjustment in patients with CKD.
• Discuss patient-centered, evidence-based approaches to CKD management, including medication management, lifestyle modifications, patient education, and social determinants of health to enhance patient outcomes.
• Understand the latest guidelines for the evaluation and management of osteoporosis, including key updates from ACP 2023.
• Identify and describe the medications used in the management of osteoporosis, focusing on their mechanisms, benefits, and potential side effects.
• Discuss patient-centered approaches to osteoporosis management, including lifestyle modifications, patient education, access to medication, and the use of medication therapies to optimize patient outcomes.
• Explain the pros and cons of enrolling in Original Medicare vs. a Medicare Advantage Plan.
• Summarize the Standard Part D benefit for 2025.
• Discuss how the Medicare Part D Redesign impacts stakeholders.
• Understand the latest guidelines and literature for the evaluation and management of obesity, including key updates from ACC/AHA/TOS and AACE/ACE.
• Identify and describe the medications used in the management of obesity, focusing on their mechanisms, benefits, potential side effects, and medication access.
• Evaluate the long-term use of GLP-1 receptor agonists in obesity management, including their impact on weight, comorbidities, and adverse effects.
• Review the management of anticoagulation, focusing on medication mechanisms, benefits, side effects and monitoring.
• Explore the latest guidelines and literature for use of DOACs in patients with obesity, cirrhosis and cancer.
• Apply best practices for periprocedural management of DOACs.
• Recognize resources for medication access for DOACs.
• Understand the role of pharmacy learners in improving population health outcomes through patient outreach and identifying healthcare gaps for closure.
• Identify successful models and strategies for integrating learners into population health pharmacy work and practice.

Electives